Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ABCELLERA BIOLOGICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 7.6M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $26.4M as of 2026-Q1. The position was decreased (-3.8% shares). ABCL represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$26.4M
Current Shares
7.6M
Total Value Change
+$12.8M
Total Shares Change
+3M
Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors
Decreased |
| 7.6M |
-3.8% |
| $26.4M |
| 0.0% |
| $3.71 |
0 |
| 2025-Q4 | New | 7.9M | - | $26.9M | 0.0% | $3.45 | 40 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $4.87 | 0 |
| 2025-Q2 | Decreased | 8.5M | -45.9% | $29.1M | 0.0% | $3.61 | 0 |
| 2025-Q1 | Increased | 15.7M | +248.3% | $34.9M | 0.0% | $2.31 | 47 |
| 2024-Q4 | Decreased | 4.5M | -2.0% | $13.2M | 0.0% | $2.82 | 0 |
| 2024-Q3 | Decreased | 4.6M | -0.2% | $11.9M | 0.0% | $2.61 | 0 |
| 2024-Q2 | New | 4.6M | - | $13.6M | 0.0% | $2.96 | 39 |